Clinic

The patient perspective is important in all medical research, and particularly in drug development. This is reflected in the European research initiative PREFER in which a research group at the Department of Medicine 3 is involved.

A study shows a new, surprising role played by blood vessels: under certain conditions they can inhibit tumor growth.

Around 400,000 people in Germany suffer from chronic inflammatory bowel disease. Researchers at the Faculty of Medicine have recently published findings showing that a special technique can improve the examination procedure for the disease.

About 80% of deaths caused by chronic, non-communicable diseases occur in low or middle income countries. Patients are often uninformed about causes and treatment options, which can lead not only to a deterioration in their state of health, but also to social exclusion. Improving health education and patient-oriented care offer considerable opportunities for prevention and treatment of chronic diseases.

A research team at the Department of Medicine 3 has discovered a mechanism that stops chronic inflammation.

How likely do patients develop again cancer after a tumor has been surgically removed? This is the central question of the new research project „MelEVIR – Melanoma, Extracellular Vesicles, and Immune Response“.